Plexxikon Inc

Centivax, Inc is a biotech company based in South San Francisco, CA, dedicated to accelerating the world's transition to a post-pathogen humanity. They are currently developing a groundbreaking broad-spectrum vaccine for the prevention of all influenza, which has been recognized with a Gates Foundation Grand Challenge End the Pandemic Threat and featured in the Netflix docuseries "Pandemic: How to Prevent an Outbreak." With a focus on pre-clinical development in ferrets and pigs, Centivax aims to revolutionize the field of vaccination and contribute to global health by combatting infectious diseases. Stay updated on their progress by following their CEO, Dr. Jacob Glanville, on social media.Generated from the website

Felix Biotechnology, Inc. is located in South San Francisco, CA, and is currently represented by the domain felixbt.com, which may be available for purchase by its owner. The website, generated through Sedo Domain Parking, indicates that Sedo does not have a relationship with third-party advertisers or endorse any specific services or trademarks mentioned. The company’s digital presence reflects its branding efforts, although specific details about its operations or offerings are not disclosed on the site. Additionally, Sedo's disclaimer clarifies that references to services or trademarks do not imply any endorsement or affiliation with Felix Biotechnology, Inc. Generated from the website

ImYoo is a Public Benefit Corporation based in South San Francisco, CA, dedicated to leveraging breakthrough multi-omic tools to uncover individuals' immune dynamics. With a patient-driven biodiscovery ecosystem, ImYoo conducts patient-centric immune discovery studies by enabling patients to self-collect small volumes of blood at home for high-resolution single-cell genomics assays, aiming to predict kidney transplant rejection and enable precision diagnosis and therapies. By capturing relevant events as they happen and understanding the complexities of diseases, ImYoo strives to advance medical research and technology, offering opportunities for patients, clinicians, researchers, funders, and other stakeholders to participate in their studies and stay updated on their groundbreaking work.Generated from the website